Human papillomaviruses target differentiating epithelia for virion production and malignant conversion

Seminars in Virology

Volumn 7, Issue 5, 1996, Pages 305-313

  Laimins, Laimonis A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cervical cancer; Epithelia; High risk types; HPV; Progression

Indexed keywords

VIRUS DNA; VIRUS PROTEIN;

CARCINOGENESIS; CELL DIFFERENTIATION; GENE MUTATION; HUMAN; LIFE CYCLE; NONHUMAN; REVIEW; TRANSCRIPTION REGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX EPITHELIUM; VIRION; VIRUS GENE; VIRUS INFECTION; VIRUS REPLICATION; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0030267240     PISSN: 10445773     EISSN: None     Source Type: Journal    
DOI: 10.1006/smvy.1996.0038     Document Type: Review

References (63)

1. 1. Howley PM (1992) Papillomavirinae: The viruses and their replication, in Fundamental Virology (Fields BN, Knipe DM, Howley PM, Chanock RM, eds) pp 947-978. Raven Press, New York
2. 2. Blanton R, Colterra MD, Gown A, Halbert C, McDougall JK (1992) Expression of the HPV 16 E7 gene generates proliferation in stratified squamous cell cultures which is dependent upon p53 levels. Cell Growth Diff 3:791-802
3. 3. Laimins LA (1993) The biology of human papillomaviruses: from warts to cancer. Infect Agents Dis 2:74-86
4. 4. deVilliers E-M (1989) Heterogeneity of the human papillomavirus group. J Virol 63:4898-4903
5. 5. Parkin DM, Laara E, Muir CS (1988) Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41:184-192
6. 6. Singer A, Ho L, Terry G, Kwie TS (1995) Association of human papillomavirus with cervical cancer and precancer. pp 103-129 Edward Arnold, London
7. 7. Lorincz AT, Reid R, Jensen AB, Greenberg MD, Lancaster W, Kurman RJ (1992) Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 79:328-337
8. 8. Androphy EJ, Hubbert NL, Schiller JT, Lowy DR (1986) Identification of the HPV E6 protein from transformed mouse and human carcinoma cell lines. EMBO J 6:989-992
9. 9 Grossman SR, Mora R, Laimins LA (1989) Intracellular localization and DNA binding properties of the HPV 18 E6 protein expressed with a baculovirus vector. J Virol 63:366-374
10. 10. Huibregtse JM, Scheffner M, Howley PM (1993) Cling and expression of the cDNA for E6-AP, a protein that mediates the interaction of HPV E6 oncoproteins with p53. Mol Cell Biol 13:775-784
11. 11. Scheffner M, Werness BA, Huibregste JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by HPV 16 and 18 promotes the degradation of p53. Cell 63:1129-1136
12. 12. Chen JJ, Reid CE, Band V, Androphy EJ (1995) Interaction of papillomavirus E6 proteins with a putative calcium binding protein. Science 269:529-532
13. 13. Dyson N, Howley PM, Munger K, Harlow E (1989) The human papillomavirus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937
14. 14. Heck DV, Yee CL, Howley PM, Munger KM (1992) Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of human papillomaviruses. Proc Natl Acad Sci USA 89:4442-4446
15. 15. Schmitt A, Harry JB, Rapp B, Wettstein FO, Iftner T (1994) Comparison of the properties of the E6 and E7 genes of low and high risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low risk HPV 1. J Virol 68:7051-7059
16. 16. Cheng S, Schimdt-Grimminger S-D, Murant T, Broker TR, Chow LT (1995) Differendation-dependent up-regulation of HPV E7 reactivates cellular DNA replication in suprabasal differentiated cells. Genes Dev 9:2335-2349
17. 17. Tommasino M, Adamczewski JP, Carlotti F, et al (1993) HPV 16 E7 protein associates with the protein kinase p33cdk2 and cyclin A. Oncogene 8:195-202
18. 18. McIntyre MC, Ruesch MN, Laimins LA (1996) HPV E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107. Virology 215:73-82
19. 19. Antinore MJ, Birrer MJ, Patel D, Natel L, McCance DJ (1996) The HPV 16 E7 gene product interacts with and transactivates the Ap-1 family of transcription factors. EMBO J 15:1950-1960
20. 20. Ustav M, Stenlund A (1991) Transient replication of BPV-1 requires two polypeptides encoded by the E1 and E2 open reading frames. EMBO J 10:449-457
21. 21. Yang L, Mohr I, Li R, Nottoli S, Sun S, Botchan M (1993) The E1 protein of BPV-1 is an ATP-dependent DNA helicase. Proc Natl Acad Sci USA 90:5086-5090
22. 22. Wilson V, Ludes-Meyers J (1992) A BPV E1 related protein binds specifically to bovine papillomavirus DNA. J Virol 65:5314-5322
23. 23. Mohr IJ, Clark R, Sun S, Androphy E, MacPherson P, Bothchan M (1990) Targeting the E1 replication factor to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science 250:1694-1699
24. 24. Thierry F, Yaniv M (1987) the BPV-1 E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO J 6:3391-3397
25. 25. Seo Y-S, Muller F, Lusky M, et al (1993) BPV-1 encoded E2 proteins enhance binding of E1 to the BPV replication origin. Proc Natl Acad Sci USA 90:2865-2869
26. 26. Frattini MG, Laimins LA (1994) Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein. Proc Natl Acad Sci USA, 91:12398-12402
27. 27. Hegde RS, Grossman S, Laimins LA, Sigler P (1992) Crystal structure at 1.7A of the BPV-1 E2 DNA-binding domain bound to its target DNA. Nature 359:505-512
28. 28. Straight S, Hinckle PM, Jewers RJ, McCance DJ (1993) The E5 oncoprotein of HPV 16 transforms fibroblasts and effects the downregulation of the EGF receptor in keratinocytes. J Virol 67:4521-4532
29. 29. Straight SW, Herman B, McCance DJ (1995) The E5 oncoprotein of HPV 16 inhibits the acidification of endosomes in human keratinocytes. J Virol 69:3185-3192
30. 30 Conrad M, Bubb VJ, Schlegel R (1993) The HPV 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16kd pore-forming protein. J Virol 67:6170-6178
31. 31. Doorbar J, Ely S, Sterling J, McLean C, Crawford L (1991) Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature 352:824-827
32. 32. Pray TR, Laimins LA (1995) Differentiation-dependent expression of E1∧E4 proteins in cell lines maintaining episomes of human papillomavirus type 31b. Virology 206:679-685
33. 33. Sterling JC, Skepper JN, Stanley M (1993) Immunoelectron microcopical localization of HPV 16 L1 and E4 proteins in cervical keratinocytes cultured in vivo. J Invest Dermatol 100:3310-3318
34. 34. Kirnbauer RF, Booy N, Cheng DR, Lowy DR, Schiller JT (1992) Papillomavirus L1 major capsid protein self assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci USA 89:12180-12184
35. 35. Baker C, Phelps W, Lindgren V, Braun M, Gonda M, Howley PM (1987) Structural and transcriptional analyses of hPV 16 sequences in cervical carcinoma lines. J Virol 61:962-971
36. 36. Hummel M, Hudson JB, Laimins LA (1992) Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J Virol 66:6070-6080
37. 37. Crum CP, Nuovo G, Friedman D, Silverstein SJ (1988) A correlation of RNA homologues to HPV 16 open reading frames in genital precancers. J Virol 62:84-90
38. 38. Chow LT, Nasseri M, Wolinsky SM, Broker TR (1987) Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata. J Virol 61:2581-2588
39. 39. Nasseri M, Hirochika R, Broker TR, Chow LT (1987) A human papillomavirus type 11 transcript encoding an E1∧E4 protein. Virology 159:433-439
40. 40. Dollard SC, Wilson JL, Demeter LM, et al (1992) Production of human papillomavirus and modulation of the infectious program in epithelia raft cultures. Genes Dev 6:1131-1142
41. 41. Hummel M, Lim HB, Laimins LA (1995) HPV 31b late gene expression is regulated through protein kinase C-mediated changes in RNA processing. J Virol 69:3381-3388
42. 42. Chang T, Chna W, Bernard U (1989) Transcriptional activation of HPV 16 by the nuclear factor 1, Ap-1, steroid receptors and possibly a novel transcription factor. Nucl Acid Res 18:465-470
43. 43. Cripe TP, Haugen TH, Turk JP, et al (1987) Transcriptional regulation of the HPV 16 E6/ E7 promoter by a keratinocyte-dependent enhancer and by E2 transactivator and repressor gene products: implications for cervical cancer. EMBO J 6:3745-3753
44. 44. Kyo S, Tam A, Laimins LA (1995) Transcriptional activity of HPV 31b enhancer is regulated through synergistic interactions of AP1 with two novel cellular factors. Virology 211:184-197
45. 45. Grassman K, Rapp B, Maschek H, Petry K, Iftner T (1996) Identification of a differentiation-inducible promoter in the E7 open reading frame of HPV16 in raft cultures of a new line containing high copy numbers of episomal HPV 16 DNA. J Virol 70:2339-2349
46. 46. Frattini M, Lim H, Laimins LA (1996) In vitro synthesis of oncogenic human papillomaviruses requires episomal templates for differentiation-dependent late expression. Proc Natl Acad Sci USA 93:3062-3067
47. 47. DelVecchio AM, Romanczuk H, Howley PM, Baker CC (1992) Transient replication of human papillomavirus DNAs. J Virol 66:5949-5958
48. 48. Chaing CM, Ustav M, Stenlund A, Ho T, Broker TR, Chow LT (1992) Viral E and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc Natl Acad Sci USA 89:5799-5803
49. 49. Ustav E, Ustav M, Szymanski P, Stenlund A (1993) The BPV-1 origin of replication requires a binding site for the E2 transcriptional activator. Proc Natl Acad Sci USA
50. 50. Frattini MG, Laimins LA (1994) The role of the E1 and E2 proteins in the replication of human papillomavirus type 31b. Virology 204:799-804
51. 51. Sverdop F, Khan S (1995) Two E2 binding sites alone are sufficient to function as the minimal origin of replication for HPV 18. J Virol 69:1319:1323
52. 52. Lu JZ, Sun YN, Rose R, Bonnez W, McCance DJ (1993) Two E2 binding sites (E2bs) alone or one E2bs plus an A/ T rich region are minimal requirements for replication of the HPV 11 origin. J Virol 67:7131-7139
53. 53. Piirsoo M, Ustav E, Mandel T, Stenlund A, Ustav M (1996) Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator. EMBO J 15:1-11
54. 54. Kieff E (1996) Epstein-Barr Virus and its replication pp 1109-1161. Raven Press, New York
55. 55. Kreider JW, Howett MK, Leure-Dupree AE, Zaino RJ, Weber JA (1987) Laboratory production in vivo of infectious human papillomavirus type 11. J Virol 61:590-593
56. 56. Sterling J, Stanley M, Gatward G, Minson T (1990) Production of human papillomavirus type 16 virions in a keratinocyte cell line. J Virol 64:6305-6307
57. 57. Asselineau D, Bernard BA, Bailly C, Darmon M, Prunieras M (1986) Human epidermis reconstructed by vulture: is it normal? J Invest Dermatol 86:181-186
58. 58. McCance D, Kopan R, Fuchs E, Laimins LA (1988) Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc Natl Acad Sci USA 85:7169-7173
59. 59. Meyers C, Frattini MG, Hudson JB, Laimins LA (1992) Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257:971-973
60. 60. Courturier J, Sastre-Garau X, Schneider-Mounnoury S, Labib A, Orth G (1991) Integration of papillomavirus near myc genes in genital carcinoma and its consequence for proto-oncogene expression. J Virol 65:4534-4538
61. 61. Klingelhultz AJ, Smith P, Garrett LR, McDougall JK (1993) Alteration of the DCC tumor-suppressor gene in tumorigenic HPV 18 immortalized human keratinocytes transformed by nitrosurea. Oncogene 8:95-99
62. 62. Cullen AP, Reid R, Campion M, Lorincz AT (1991) Analysis of the physical state of different human papillomavirus DNAs in intraepithelial neoplasia and invasive cervical carcinoma. J Virol 65:606-612
63. 63. Sherman L, Alloul N, Golan I, Durst M, Baram A (1992) Expression and splice patterns of HPV 16 mRNAs in precancerous lesions and carcinomas of the cervix in keratinocytes immortalized by HPV 16 and in lines established from cervical cancers. Int J Cancer 50:356-364